Special items: Ovarian Cancer and Us blog best viewed in Firefox

Sunday, February 01, 2009

Anlaysis of hMLH1 and hMSH2 expression Cisplating-treated ovarian cancer patients

HighWire Press -- Medline Abstract

"CONCLUSION: The immunohistochemical expression of hMLH1 and hMSH2 proteins in ovarian cancer has no predictive value in resistance to cisplatin."

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.